observed a strong trend towards lower risks of bleeding events with DOAC usage, although this did not achieve statistical significance.
← all excerpts
Real-World Efficacy and Safety of Apixaban vs. Warfarin in Obese Atrial Fibrillation Patients: Propensity Matching Analysis.
1
—
—